Skip to main content
Premium Trial:

Request an Annual Quote

MWG Biotech, Qiagen, Dharmacon


MWG Biotech has recently introduced the siMax siRNA design tool.

According to MWG, the online tool allows researchers to view the secondary structure of their mRNA target sequence at the siRNA site before they order their oligos from the company.

Additional details about the tool can be found at

Qiagen is preparing to launch the GeneGlobe database, a collection of matching solutions for RNAi and gene-expression analysis covering the entire human, mouse, and rat genomes.

In the database, researchers can find more than 70,000 pre-designed siRNAs and validated SYBR Green-based qRT-PCR assays.

The database can be accessed at beginning April 29, Qiagen said.

Dharmacon announced the availability of its siArray reverse transfection (RTF) siRNA libraries last week.

According to the company, the libraries are designed for the effective delivery of siRNA to mammalian cells in a high-throughput screening, reverse-transfection format for the study of entire gene families or regulatory pathways. They are also supplied with the siRNA reagents pre-dispensed into 96-well plates that also include positive and negative controls.

By eliminating multiple pipetting, dilution, and other liquid-dispensing steps, Dharmacon said its RTF platform can reduce the opportunity for errors and exposure to environmental conditions that may cause degradation of RNA.

Dharmacon said it is also offering siArray RTF optimization plates, which can be used to optimize the reverse-transfection process in specific cell lines before experiments with the actual libraries are conducted.

Additional details about the RTF libraries can be found at /catalog/siarrayrtf/?SOURCE=0.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.